Publications

Hogan Lovells Publications

HHS tackles barriers to value-based care: Part two – Substantial Stark Law regulatory revisions proposed Health Alert

Along with proposed Stark Law exceptions designed to accommodate value-based care models, the Centers for Medicare & Medicaid Services (CMS or the agency) proposed additional revisions...

Hogan Lovells Publications

HHS tackles barriers to value-based care: Part 1 – new protections for value-based arrangements under Stark and the AKS and other key AKS changes

Nearly a decade after the Affordable Care Act signaled a transition of the U.S. health care system to value-based care, the Department of Health and Human Services (HHS) published on...

Hogan Lovells Publications

A bit more Sunshine: CMS proposes collecting additional information on manufacturer payments under the Open Payments program Health Alert

Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services...

Hogan Lovells Publications

Senate Finance Committee releases details of drug pricing bill Life Sciences & Health Care Alert

Yesterday, the Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Oregon) released a description of The Prescription Drug Pricing Reduction Act of...

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Value-based purchasing

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.

Hogan Lovells Publications

Medicare further expands payment for and coverage of telehealth and similar services Health Alert

Through several recently published rules, the Centers for Medicare & Medicaid Services (CMS) is making it possible for Medicare beneficiaries to have greater access to health care...

Hogan Lovells Publications

New anti-kickback prohibition in opioid bill creates tangled web of compliance obligations Pharmaceutical and Biotechnology Alert

On October 3, the U.S. Congress passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (the SUPPORT...

Loading data